Join the Melanoma group to help and get support from people like you.
Melanoma News
Related terms: Cancer, Melanoma, Malignant Melanoma, Skin Cancer, Melanoma
Long-Term Survival Benefit Seen for Nivolumab in Advanced Melanoma
THURSDAY, Sept. 19, 2024 – For patients with advanced melanoma, there is a survival benefit for nivolumab plus ipilimumab and for nivolumab monotherapy compared with ipilimumab monotherapy,...
Study Looks at Sex Differences in Melanoma Incidence
TUESDAY, Sept. 17, 2024 – Melanoma rates differ for men and women, including in terms of ages of occurrence and locations of melanoma, according to a study published online June 17 in the Journal of...
Immunotherapy Drugs Extend Survival for Patients With Advanced Melanomas
MONDAY, Sept 16, 2024 – A decade of patient follow-up finds a combo of two immunotherapy drugs can greatly extend survival for people with advanced melanomas. In 2011, a diagnosis of advanced,...
Melanoma Incidence, Mortality Declining in Those Aged 30 to 49 Years
TUESDAY, Sept. 10, 2024 – For adults aged 30 to 49 years, there has been a decline in melanoma incidence and mortality, according to a study published online Sept. 8 in JAMA Dermatology to coincide...
Gene Expression Signature Predicts Immune-Related Adverse Events in Melanoma Patients
MONDAY, Aug. 12, 2024 – A gene expression signature in peripheral CD4+ T-cells can predict severe immune-related adverse events (irAEs) among melanoma patients treated with ipilimumab/nivolumab,...
Prevalence of Skin Cancer Varies for Sexual Minority, Heterosexual Adults
FRIDAY, July 19, 2024 – With respect to their lifetime prevalence of skin cancer, sexual minority (SM) adults differ across racial and ethnic groups and among males and females, according to a study...
Respect Summer's Scorching Heat, Experts Warn
SATURDAY, July 13, 2024 – The human body is no match for extreme heat, and scorching temperatures seem to be the rule rather than the exception these days. "It's hard to think of an organ that is...
Have Fun in the Sun, But Protect Your Skin, Expert Says
SUNDAY, July 14, 2024 — Roughly 20% of Americans are diagnosed with skin cancer at some point in their lives, but it's not inevitable. Skin cancer is not only the most common cancer, it's also the m...
Rural Residents Continue to Have Higher Odds of Skin Cancer
TUESDAY, July 9, 2024 – Urban-rural disparities in skin cancer prevalence continue to persist, according to a study published in the June issue of the Journal of Drugs in Dermatology. Rachel R. Lin, ...
ASCO: Neoadjuvant Ipilimumab + Nivolumab Ups Survival in Resectable Melanoma
WEDNESDAY, June 5, 2024 – Neoadjuvant ipilimumab plus nivolumab followed by surgery results in longer event-free survival than surgery followed by adjuvant nivolumab among patients with resectable,...
Non-Hispanic Black Melanoma Patients Present With Advanced Disease
WEDNESDAY, May 15, 2024 – Non-Hispanic Black (NHB) melanoma patients have distinct tumor characteristics, presenting with more advanced disease and exhibiting worse outcomes, according to a study...
Melanoma Can Strike Black Americans, Often With Deadlier Results
TUESDAY, May 14, 2024 – Melanoma, while rare among Black Americans, is often detected later with devastating consequences, a new study finds. Black people are frequently diagnosed with melanoma at...
Outdoor Workers Face Skin Cancer Danger
FRIDAY, May 10, 2024 – Steve Murray, 68, has spent a lot of time out in the sun, at work and at play. Murray worked construction for several decades, and as a child spent summers on the beach in...
A Third of Young Adults Still Believe 'Tan Is Healthier' Myth: Survey
THURSDAY, May 2, 2024 – Brianna Starr, 29, didn’t think twice about sunbathing without sunscreen, hoping to get a golden tan that to many connotes health and beauty. But when her sister was d...
'Virtual Biopsy' Tests Skin Lesions Without a Scalpel
FRIDAY, April 12, 2024 – Folks with a suspicious-looking mole or questionable skin lesion often have to endure a scalpel or shaver so their doctor can cut off a sample to send in for biopsy. But a...